Brian A. Donahue

Sr Patent Agent | Palo Alto | (650) 813-5632
(650) 813-5632

Brian Donahue is a senior patent agent in the Intellectual Property Practice Group of Morrison & Foerster’s Palo Alto office. Dr. Donahue practices in the area of biotechnology. He has extensive experience in patent drafting and patent prosecution before the United States Patent and Trademark Office, and in coordination of patent prosecution in other jurisdictions in association with foreign patent counsel. He also has substantial expertise in patent portfolio analyses and management, prior art searching, and due diligence inquiries, including freedom-to-operate analysis and intellectual property landscape analysis. Dr. Donahue has worked with a wide range of clients, including startup biotech companies, large pharmaceutical companies, universities, and independent inventors. Representative clients for whom Dr. Donahue has performed patent work for include Children’s Hospital of Oakland Research Institute, Genentech, Genzyme, and VistaGen Therapeutics.

Dr. Donahue has prosecuted patent applications in several areas of biotechnology, including gene therapy, antibodies, stem cells, peptide and polypeptide therapeutics, chromatography, and formulations.

Dr. Donahue received his B.A. in biology from the University of Vermont and his Ph.D. in toxicology from the Massachusetts Institute of Technology. His thesis research, in the laboratory of Dr. John Essigmann, focused on cellular responses to DNA damage by the anti-tumor drug cisplatin. He was awarded a pre-doctoral fellowship from the Surdna Foundation and was the recipient of the Myriam Znaty Award for research excellence. He subsequently joined the laboratory of Dr. Philip Hanawalt at Stanford University, where he investigated molecular mechanisms of transcription-coupled DNA repair. He was awarded a post-doctoral fellowship from the American Cancer Society. Prior to joining Morrison & Foerster, Dr. Donahue was a research scientist at Cell Genesys, where he developed adeno-associated viral vectors for gene therapy. He is the author of many peer-reviewed journal articles and has presented his research at a number of scientific conferences. Dr. Donahue is registered to practice before the U.S. Patent and Trademark Office.

Show More


Unsolicited e-mails and information sent to Morrison & Foerster will not be considered confidential, may be disclosed to others pursuant to our Privacy Policy, may not receive a response, and do not create an attorney-client relationship with Morrison & Foerster. If you are not already a client of Morrison & Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.